Derby Royal Hospital, University Hospitals of Derby and Burton NHS Trust, Derby, UK.
Surgery Working Group, Society of Junior Doctors, Athens, Greece.
Obes Surg. 2021 Apr;31(4):1790-1800. doi: 10.1007/s11695-020-05188-7. Epub 2021 Jan 16.
Single-anastomosis duodenoileal bypass with sleeve gastrectomy/one anastomosis duodenal switch (SADI-S/OADS) was developed as a bariatric operation with reduced overall morbidity and lasting weight loss results. We performed a systematic review of the literature, including 14 studies reporting on weight loss, comorbidity resolution, postoperative complications, and nutritional deficiencies following SADI-S. Twelve months after SADI-S, the mean total body weight lost ranged from 21.5 to 41.2%, with no weight regain being observed after 24 months. The comorbidity resolution rate was 72.6% for diabetes, 77.2% for dyslipidemia, and 59.0% for hypertension cases. The need for reoperation was the most common postoperative complication. While several patients developed nutrient deficiencies, SADI-S seems to be an overall safe and effective bariatric operation.
单吻合口十二指肠空肠旁路术联合袖状胃切除术/十二指肠空肠转流术（SADI-S/OADS）作为一种减重手术，具有降低整体发病率和持久的减重效果。我们对文献进行了系统回顾，包括 14 项研究，报告了 SADI-S 术后的体重减轻、合并症缓解、术后并发症和营养缺乏情况。SADI-S 术后 12 个月，平均总体体重减轻率为 21.5%至 41.2%，24 个月后未观察到体重反弹。糖尿病的缓解率为 72.6%，血脂异常为 77.2%，高血压为 59.0%。再次手术是最常见的术后并发症。虽然有一些患者出现了营养缺乏，但 SADI-S 似乎是一种安全有效的减重手术。
